# Fidelity Biosciences

> Fidelity Biosciences is a VC fund backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 4
- Last investment: Nov 2014
- Lead investor: 25%
- Last updated: Aug 2026

Fidelity Biosciences is a VC fund focused on Health Care and Biotechnology. Fidelity Biosciences

## Contacts

5 contacts available for Fidelity Biosciences. Shizune tracks 1 team members at Fidelity Biosciences. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fidelity-biosciences?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Biotechnology | 3 | 75% |
| Pharmaceutical | 2 | 50% |
| Medical | 1 | 25% |
| Bioinformatics | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 50% |
| Series C | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jon Lim | Partner | 18 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Blueprint Medicines | Blueprint Medicines develops targeted therapies for cancer and blood disorders, focusing on precision medicine. The company utilizes genetic insights to design treatments tailored to individual patient needs. Their portfolio includes products aimed at specific mutations and conditions, enhancing treatment options for patients with various types ofcancer and hematologic diseases. Blueprint Medicines collaborates with healthcare providers to ensure that their therapies are accessible and effectively integrated into patient care. Through ongoing research and development, the company aims to expand its offerings and address unmet medical needs in oncology and hematology. | $50M | Series C | Nov 12, 2014 |  |
| NeuroTherapeutics Pharma | NeuroTherapeutics Pharma, Inc., a biopharmaceutical company, develops therapeutics for patients suffering from central nervous system disorders. It focuses on epilepsy, neuropathic, and acute pain disorders of the nervous system. The company was incorporated in 2006 and is based in Chicago, Illinois. |  | Series B | May 20, 2010 |  |
| Cardiokine | Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004and is headquartered in Philadelphia, Pennsylvania. | $50M | Series B | May 01, 2006 |  |
| Kyruus Health | Kyruus Health is a care access platform that provides solutions for providers data management, patient engagement, and activation. |  | Series C |  |  |

4 of 4 investments shown.

## Co-investors
- [Advent Venture Partners](https://shizune.co/investors/profile/advent-venture-partners) — VC Fund, 1 deal together
- [Burrill & Company](https://shizune.co/investors/profile/burrill-co) — VC Fund, 1 deal together
- [Care Capital](https://shizune.co/investors/profile/care-capital) — VC Fund, 1 deal together
- [Casdin Capital](https://shizune.co/investors/profile/casdin-capital) — VC Fund, 1 deal together
- [CIBC Capital Partners](https://shizune.co/investors/profile/cibc-capital-partners) — VC Fund, 1 deal together
- [Cowen Group](https://shizune.co/investors/profile/cowen-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Fidelity Biosciences invest in?

Fidelity Biosciences invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Fidelity Biosciences?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fidelity Biosciences?

The team at Fidelity Biosciences includes Jon Lim (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co